Bortezomib-Induced Peripheral Neuropathy in Patients With Multiple Myeloma

被引：11

作者：

Berkowitz, Anne ^{[1
]}

Walker, Suzanne ^{[2
]}

机构：

[1] Univ Penn, Hematol Bone Marrow Transplant Dept, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[2] Penn Presbyterian Med Ctr, Philadelphia, PA USA

来源：

CLINICAL JOURNAL OF ONCOLOGY NURSING | 2012年 / 16卷 / 01期

关键词：

MANAGEMENT; THERAPY;

D O I：

10.1188/12.CJON.86-89

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Bortezomib-induced peripheral neuropathy (BIPN) often is difficult to manage or reverse once it occurs. Treatment usually involves dose-reduction, interruption, or cessation of therapy, as no other interventions have been proven effective. Oncology nurses must be vigilant and recognize BIPN early to prevent patients from experiencing symptoms and complications that may interfere with their quality of life.

引用

页码：86 / 89

页数：4

共 50 条

[31] Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy
Yamamoto, Shota
Egashira, Nobuaki
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (02) : 1 - 14
[32] Bortezomib-induced rhabdomyolysis in multiple myeloma
Cibeira, M. Teresa
Mercadal, Santiago
Arenillas, Leonor
Muntanola, Anna
Salamero, Olga
Blade, Joan
ACTA HAEMATOLOGICA, 2006, 116 (03) : 203 - 206
[33] Bortezomib-induced peripheral neuropathy is related to altered levels of brain-derived neurotrophic factor in the peripheral blood of patients with multiple myeloma
Azoulay, David
Lavie, David
Horowitz, Netanel
Suriu, Celia
Gatt, Moshe E.
Akria, Luiza
Perlman, Riki
Braester, Andrei
Ben-Yehuda, Dina
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (03) : 454 - 456
[34] THE CLINICAL SPECTRUM OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY
Mauermann, M. L.
Dispenzieri, A.
Staff, N. P.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 : S85 - S85
[35] An Atypical Presentation of Bortezomib-Induced Peripheral Neuropathy
Santilli, Ashley
Martinez-Thompson, Jennifer
NEUROLOGY, 2021, 96 (15)
[36] A prospective study of bortezomib-induced peripheral neuropathy
Briemberg, HR
Richardson, PG
Wen, P
Esseltine, DL
Anderson, K
Amato, AA
NEURO-ONCOLOGY, 2004, 6 (04) : 371 - 371
[37] Risk Factor Analysis of Bortezomib Induced Peripheral Neuropathy in Patients with Multiple Myeloma
Turgut, Nilda
Turgut, Burhan
Tekinalp, Atakan
Erdogan, Hasan
Kurtulus, Nursen
Cicek, Emre
ANNALS OF NEUROLOGY, 2014, 76 : S68 - S68
[38] Clinical significance of SIRT3 and inflammatory factors in multiple myeloma patients with bortezomib-induced peripheral neuropathy: a cohort study
Yang, Huiqi
Liu, Can
Yuan, Fen
Li, Fang
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2021, 81 (08): : 615 - 621
[39] A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
Magrangeas, Florence
Kuiper, Rowan
Avet-Loiseau, Herve
Gouraud, Wilfried
Guerin-Charbonnel, Catherine
Ferrer, Ludovic
Aussem, Alexandre
Elghazel, Haytham
Suhard, Jerome
Sakissian, Henri Der
Attal, Michel
Munshi, Nikhil C.
Sonneveld, Pieter
Dumontet, Charles
Moreau, Philippe
van Duin, Mark
Campion, Loic
Minvielle, Stephane
CLINICAL CANCER RESEARCH, 2016, 22 (17) : 4350 - 4355
[40] Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature (vol 112, pg 1593, 2008)
Argyriou, A. A.
Iconomou, G.
Kalofonos, H. P.
BLOOD, 2009, 113 (18) : 4478 - 4478

← 1 2 3 4 5 →